Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB26FM8ER
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,190
Award facts
- Contract value 100% obligated
- $6,189.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,189.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of XOLAIR 150 mg/1.2 mL powder vials. The delivery order, which was awarded on October 17, 2025, with an ultimate completion date of November 7, 2025, carries no set-aside designation and represents a routine pharmaceutical procurement to support Department of Defense medical supply requirements. DMS Pharmaceutical Group will perform all work at its facility in Park Ridge, Illinois.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion governmentwide acquisition strategy designed to provide a stable, efficient supply chain for pharmaceutical products to military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and extending through December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription medications, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established performance on numerous delivery orders across diverse pharmaceutical categories demonstrates its capability as a critical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FM8ER?
SPE2DB26FM8ER was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 17, 2025.
How much is contract SPE2DB26FM8ER worth?
The government has obligated $6,190 on SPE2DB26FM8ER.
Is contract SPE2DB26FM8ER an order under another contract?
Yes. SPE2DB26FM8ER is a delivery order under SPE2DB22D9151, an indefinite delivery contract.
Was contract SPE2DB26FM8ER competed?
The extent of competition for SPE2DB26FM8ER was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award